Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Tomando las calles - La campaña de concientización Vaccinate4Love: Orden del Doctor se presenta en los kioscos de LinkNYC por toda la ciudad de Nueva York
  • USA - Traditional Chinese
  • USA - Chinese
  • USA - English

Somos un grupo conformado por los mejores médicos y estrategas de comunicaciones del país, quienes hemos aunado fuerzas para elaborar una campaña de concientización del público que invita a los pacientes y a las comunidades a no dudarlo y vacunarse tan pronto como sea posible, para su propio beneficio, el de sus familias, sus comunidades y el mundo. Para obtener más información, visite https://vaccinate4love.org. (PRNewsfoto/Vaccinate4Love)

News provided by

Vaccinate4Love

May 19, 2021, 11:28 ET

Share this article

Share toX

Share this article

Share toX

New York Yankees, LinkNYC, Transit Wireless, Cision PR Newswire, United Way y Grand Central Partnership se unen a los socios estratégicos de la campaña Vaccinate4Love para combatir las dudas frente a la vacuna

NUEVA YORK, 19 de mayo de 2021 /PRNewswire-HISPANIC PR WIRE/ -- Si bien la vacunación completa se ha convertido en la clave nacional para poder dejar de usar las mascarillas, con las dudas aún en aumento vertiginoso, "los esfuerzos para superar las dudas frente a la vacuna cada vez resultan de mayor urgencia", afirmaron la Dra.  Jacqueline Jones y Davia Temin, cofundadoras de la campaña local de concientización pública Vaccinate4Love: Orden del Doctor.

Continue Reading
La campaña de concientización Vaccinate4Love se presenta en los kioscos LinkNYC en la ciudad de Nueva York (PRNewsfoto/Vaccinate4Love)
La campaña de concientización Vaccinate4Love se presenta en los kioscos LinkNYC en la ciudad de Nueva York (PRNewsfoto/Vaccinate4Love)

En respuesta a esta necesidad, LinkNYC, la particular red de comunicaciones que ofrece Wi-Fi, llamadas telefónicas, carga de dispositivos y servicios sociales de forma gratuita, se asoció con Vaccinate4Love para difundir el mensaje por las calles de Nueva York. Vallas digitales con mensajes que invitan a que "No lo dudes - Vacuna" ("Don't Hesitate – Vaccinate") se están presentando ahora en 1,800 kioscos por toda el área metropolitana de Nueva York. A la fecha, las tasas de vacunación para residentes de 18 años o más varían significativamente entre distritos, desde un 31 % de adultos residentes en el Bronx completamente vacunados hasta un 50 % en Manhattan. Brooklyn tiene un 34 % de vacunación completa entre sus residentes, mientras que Staten Island está en el 38 % y Queens en el 41 %.

Además de la alianza con LinkNYC, los nuevos socios estratégicos de Vaccinate4Love incluyen a Cision PR Newswire, Grand Central Partnership, New York Yankees, Transit Wireless, United Way, y muchos más. La campaña @Vaccinate4Love, que se lanzó en marzo, se ha difundido a nivel nacional por Facebook, Twitter, Instagram, TikTok, YouTube y LinkedIn.

Las dudas frente a la vacuna a lo largo del país han llevado a predicciones pesimistas acerca de alcanzar la inmunidad de rebaño completa en los Estados Unidos este año, para lo cual los científicos estiman se requeriría un alcance de entre el 70 y el 80 % de la población. La administración Biden estableció el objetivo de que, para el 4 de julio, el 70 % de la población de los Estados Unidos ya haya recibido al menos la primera dosis.

"Nos sentimos orgullosos de poder utilizar nuestras vallas para ayudarle a Vaccinate4Love a promover este importante mensaje público entre las comunidades a lo largo de Nueva York", expresó Esther Raphael, directora de Marketing de Intersection, una de las compañías detrás del programa LinkNYC.

La campaña Vaccinate4Love cuenta con el respaldo de un grupo de aliados estratégicos entre los que se encuentran:

  • Brandloft
  • Castle Connolly
  • Cision PR Newswire
  • Everyday Health
  • FXCollaborative
  • Garfunkel Wild, PC
  • Global Peace Film Festival
  • Glow Beauty Magazine
  • Grand Central Partnership
  • HPV Alliance
  • LinkNYC
  • MD Publish.com
  • New York Yankees
  • Operation Warrior Shield
  • Partnership for NYC
  • Plan Heal
  • Real Estate Board of NY
  • Temin and Company
  • Transit Wireless
  • United Way
  • Vax'n 8
  • Vax 2 Stop Cancer
  • Vital Strategies

Cada semana se unen más aliados. Por favor, diríjase a vaccinate4love.org para obtener más información y recursos gratuitos, incluidos pósteres, volantes, publicaciones para redes sociales, fondos de pantalla para Zoom y marcos de "Vaccinate4Love" de Facebook.

Siga a #Vaccinate4Love en:

  • Facebook: https://www.facebook.com/Vaccinate4Love
  • Twitter: @Vaccinate4Love https://twitter.com/Vaccinate4Love
  • Instagram: https://www.instagram.com/vaccinate4love
  • LinkedIn: https://www.linkedin.com/company/vaccinate4love
  • TikTok: https://www.tiktok.com/@vaccinate4love 
  • YouTube: https://www.youtube.com/channel/UCcg0kMO-ykX51ZWDZzSH6Nw

Acerca de #Vaccinate4Love
Somos un grupo conformado por los mejores médicos y estrategas de comunicaciones del país, quienes hemos aunado fuerzas para elaborar una campaña de concientización del público que invita a los pacientes y a las comunidades a no dudarlo y vacunarse tan pronto como sea posible, para su propio beneficio, el de sus familias, sus comunidades y el mundo.

Cofundada por la Dra.  Jacqueline Jones y Davia Temin, también contamos con Victor DeCastro, director creativo y Roger Chiocchi, estratega de marca y escritor, al igual que Rachel Clarke, Trang Mar, Suzanne Oaks Brownstein, Amy Cao y Maria Matveeva, estrategas de Temin and Company. Para obtener más información, por favor, póngase en contacto con Temin and Company en el teléfono 212.588.8788 o visitando nuestro sitio web https://vaccinate4love.org.

Fotografía: https://mma.prnewswire.com/media/1513281/Kiosk_NYv2alt.jpg
Logo - https://mma.prnewswire.com/media/1513282/vaccinate4love_Logo.jpg

FUENTE Vaccinate4Love

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.